As of May 3, 2024, the Dexcom stock's P/E ratio is 77.8. This takes into account the latest EPS of $1.65 and stock price of $128.37. The PE ratio has decreased by 23% from its last 4 quarters average of 101.5.
The PE ratio of Dexcom has averaged 139.14 over the last six years. The current price-to-earnings ratio of 77.8 is 44% less than the historical average. Analyzing the last six years, DXCM's PE ratio reached its highest point in the Sep 2018 quarter at 298, when the price was $35.76 and the EPS was $0.12. The lowest point was recorded in the Mar 2021 quarter, when it reached 57.97 with a price of $89.85 and an EPS of $1.55.
Maximum annual increase: 278.63% in 2021
Maximum annual decrease: -67.58% in 2020
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 88.64 | -31.12% |
| 2022 | 128.68 | -46.32% |
| 2021 | 239.71 | 278.63% |
| 2020 | 63.31 | -67.58% |
| 2019 | 195.3 | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
DXCM's current PE ratio is under its 3, 5 and 10-year averages.
DXCM's PE ratio is above its peer stocks JNJ and ABT. Dexcom's current PE ratio of 77.8 is more than the average of its peers, which is 34.06.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 9.78 | $359.25B |
| MDT Medtronic plc | 25.93 | $108.47B |
| ABT Abbott Laboratories | 32.79 | $184.23B |
| EW Edwards Lifesciences Corp | 36.59 | $51.32B |
| WST West Pharmaceutical Services Inc | 47.59 | $26.59B |
| BDX Becton Dickinson & Co | 51.69 | $67.82B |
| DXCM Dexcom Inc | 77.8 | $51.05B |
| TNDM Tandem Diabetes Care Inc | N/A | $2.89B |
| QDEL Quidel Corp | N/A | $2.84B |
The price to earnings ratio for DXCM stock is 77.8 as of May 3, 2024.
As an average over the last 3 years, DXCM stock has a PE ratio of 126.47.
As an average over the last 5 years, DXCM stock has a PE ratio of 130.31.
Over the last six years, the quarterly PE ratio reached its highest level at 298 in the Sep 2018 quarter.
DXCM's price to earnings ratio is currently 44% below its 6-year historical average.
A company with a higher PE ratio may indicate that the market has higher growth expectations for the company's future earnings or profitability.
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (May 3, 2024), Dexcom's share price is $128.37. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $1.65. Therefore, Dexcom's price to earnings ratio for today is 77.8. PE RATIO(77.8) = STOCK PRICE($128.37) / TTM EPS($1.65)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.